Review articles
|

Structured Antiretroviral Therapy Interruption as a form of Immune-based Therapy in HIV-1 Infection
Felipe García, José M. Miró, and José M. Gatell.
|Abstract|
|Full
Article in PDF|
|
 |

Structured Antiretroviral Treatment Interruption in Heavily-Experienced HIV-Infected Patients
Christine Katlama
|Abstract|
|Full
Article in PDF|
|
 |

HIV Compartmentalization: Pathogenesis and Clinical Implications
John R. Clarke, Natalie C. White, and Jonathan N. Weber
|Abstract|
|Full
Article in PDF|
|
 |

HHV-8, an Always Intriguing, Sometimes Relevant Herpesvirus
Marina Núñez, Ana Machuca, and Vincent Soriano
|Abstract|
|Full
Article in PDF|
|
 |

Controlled Release of Antiretroviral Drugs
Hagen von Briesen , Peter Ramge , and Jörg Kreuter
|Abstract|
|Full
Article in PDF|
|
 |

Nucleotide Substitution Rates of HIV-1
Yoshiyuki Suzuki , Yumi Yamaguchi-Kabata , and Takashi Gojobori
|Abstract|
|Full
Article in PDF|
|
 |

Psychiatric and Psychological Disorders associated to HIV Infection
Lucía Gallego , Victoria Gordillo , and José Catalán
|Abstract|
|Full
Article in PDF|
|
 |
Hot News
An old virus using chemokine receptors to enter cells might have selected for resistance to HIV infection
|Abstract|
|Full
Article in PDF|
|
 |

Putting the brakes on drug approval: Adefovir
|Abstract|
|Full
Article in PDF|
|
 |

Primary resistance to non-nucleosides
|Abstract|
|Full
Article in PDF|
|
 |

Lymphocyte chemotaxis and activation by HIV-1 Nef
|Abstract|
|Full
Article in PDF|
|
 |

Are non-nucleosides equally potent?
|Abstract|
|Full
Article in PDF|
|
 |

One step closer to HIV vaccines?
|Abstract|
|Full
Article in PDF|
|
 |